Ten-year results of intense dose-dense chemotherapy show superior survival compared with a conventional schedule in high-risk primary breast cancer: final results of AGO phase III iddEPC trial
Titel:
Ten-year results of intense dose-dense chemotherapy show superior survival compared with a conventional schedule in high-risk primary breast cancer: final results of AGO phase III iddEPC trial
Auteur:
Möbus, V. Jackisch, C. Lück, H.J. du Bois, A. Thomssen, C. Kuhn, W. Nitz, U. Schneeweiss, A. Huober, J. Harbeck, N. von Minckwitz, G. Runnebaum, I.B. Hinke, A. Konecny, G.E. Untch, M. Kurbacher, C.